Maternal serum alpha fetoprotein testing: some public policy considerations.
D000649:Amniocentesis; D003376:Counseling; D035082:Federal Government; D005260:Female; D005378:Financial Support; D006076:Government; D033161:Government Regulation; D006291:Health Policy; D006801:Humans; D008403:Mass Screening; D008484:Medicaid; D009436:Neural Tube Defects / Q000175:diagnosis*; D010344:Patient Advocacy; D011203:Poverty; D011247:Pregnancy; D037841:Pregnant People; D011296:Prenatal Diagnosis / Q000191:economics / Q000379:methods*; D011640:Public Policy; D012926:Social Control, Formal; D014463:Ultrasonography; D014481:United States; D014486:United States Food and Drug Administration; D014933:Women's Rights; D000509:alpha-Fetoproteins / Q000032:analysis*
Genetics and Reproduction; Health Care and Public Health; Medicaid